Skip to main content
Erschienen in: Metabolic Brain Disease 2/2009

01.06.2009 | Original Paper

Morphological changes of rat astrocytes induced by liver damage but not by manganese chloride exposure

verfasst von: Susana Rivera-Mancía, Sergio Montes, Maricela Méndez-Armenta, Pablo Muriel, Camilo Ríos

Erschienen in: Metabolic Brain Disease | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

Liver cirrhosis is a common cause of death around the world. One of its more severe complications is hepatic encephalopathy. As a consequence of liver impairment, manganese (Mn) and other substances accumulate in the brain. Astrocytic morphological changes have been found in postmortem brains of cirrhotic patients. In this study we used a model of cirrhosis induced by bile duct ligation and Mn accumulation by exposing rats to MnCl2 (1 mg Mn/ml) in their drinking water. Four experimental groups were used: Sham, Sham plus Mn treatment, BDL (bile duct ligated) and BDL plus Mn treatment. Brain Mn was measured by atomic absorption spectrophotometry in cortex, striatum and globus pallidus. Altered and normal astrocytes were counted in the same brain areas. Brain Mn was highest in rats of the BDLMn group. An increased number of altered astrocytes was found only in BDL groups, Mn did not modify this effect. No changes were found in the total number of astrocytes. According to our results, biliary obstruction induced an increase in the number of altered astrocytes since early stages of cirrhosis and Mn did not affect this effect.
Literatur
Zurück zum Zitat Aschner M, Gannon M (1993) Manganese (Mn) transport across the blood-brain barrier: Saturable and dependent transport mechanisms. Brain Res Bull 33:345–349CrossRef Aschner M, Gannon M (1993) Manganese (Mn) transport across the blood-brain barrier: Saturable and dependent transport mechanisms. Brain Res Bull 33:345–349CrossRef
Zurück zum Zitat Aschner M, Dorman DC (2006) Manganese: pharmacokinetics and molecular mechanisms of brain uptake. Toxicol Rev 25:147–154PubMedCrossRef Aschner M, Dorman DC (2006) Manganese: pharmacokinetics and molecular mechanisms of brain uptake. Toxicol Rev 25:147–154PubMedCrossRef
Zurück zum Zitat Aschner M, Vrana KE, Zheng W (1999) Manganese uptake and distribution in the central nervous system (CNS). Neurotoxicology 20:173–180PubMed Aschner M, Vrana KE, Zheng W (1999) Manganese uptake and distribution in the central nervous system (CNS). Neurotoxicology 20:173–180PubMed
Zurück zum Zitat Bergmeyer HU, Grabl M, Walter HE (1983) Enzymes. In: Bergmeyer J, Grabl M (eds) Methods of enzymatic analysis. Verlag-Chemie, Weinheim, pp 269–270 Bergmeyer HU, Grabl M, Walter HE (1983) Enzymes. In: Bergmeyer J, Grabl M (eds) Methods of enzymatic analysis. Verlag-Chemie, Weinheim, pp 269–270
Zurück zum Zitat Bosetti C, Levi F, Lucchini F, Zatonski WA, Negri E, La Vecchia C (2007) Worldwide mortality from cirrhosis: an update to 2002. J Hepatol 46:827–839PubMedCrossRef Bosetti C, Levi F, Lucchini F, Zatonski WA, Negri E, La Vecchia C (2007) Worldwide mortality from cirrhosis: an update to 2002. J Hepatol 46:827–839PubMedCrossRef
Zurück zum Zitat Butterworth RF (2000) Complications of cirrhosis III. Hepatic encephalopathy. J Hepatol 32(1 Suppl):171–180PubMedCrossRef Butterworth RF (2000) Complications of cirrhosis III. Hepatic encephalopathy. J Hepatol 32(1 Suppl):171–180PubMedCrossRef
Zurück zum Zitat Butterworth RF (2001) Neurotransmitter dysfunction in hepatic encephalopathy: new approaches and new findings. Metab Brain Dis 16:55–65PubMedCrossRef Butterworth RF (2001) Neurotransmitter dysfunction in hepatic encephalopathy: new approaches and new findings. Metab Brain Dis 16:55–65PubMedCrossRef
Zurück zum Zitat Butterworth RF (2002) Pathophysiology of hepatic encephalopathy: a new look to ammonia. Metab Brain Dis 17:221–227PubMedCrossRef Butterworth RF (2002) Pathophysiology of hepatic encephalopathy: a new look to ammonia. Metab Brain Dis 17:221–227PubMedCrossRef
Zurück zum Zitat Calne DB, Chu NS, Huang CC, Lu CS, Olanow W (1994) Manganism and idiopathic parkinsonism: similarities and differences. Neurology 44:1583–1586PubMed Calne DB, Chu NS, Huang CC, Lu CS, Olanow W (1994) Manganism and idiopathic parkinsonism: similarities and differences. Neurology 44:1583–1586PubMed
Zurück zum Zitat Chia SE, Foo SC, Gan SL, Jeyaratnam J, Tian CS (1993) Neurobehavioral functions among workers exposed to manganese ore. Scand J Work Environ Health 19:264–270PubMed Chia SE, Foo SC, Gan SL, Jeyaratnam J, Tian CS (1993) Neurobehavioral functions among workers exposed to manganese ore. Scand J Work Environ Health 19:264–270PubMed
Zurück zum Zitat Glossman M, Neville DM (1972) Gamma-Glutamyl transferase in kidney brush border membranes. FEBS Lett 19:340–344CrossRef Glossman M, Neville DM (1972) Gamma-Glutamyl transferase in kidney brush border membranes. FEBS Lett 19:340–344CrossRef
Zurück zum Zitat Hazell AS, Normandin L, Norenberg MD, Kennedy G, Jae-Hyuk Y (2006) Alzheimer type II astrocytic changes following sub-acute exposure to manganese and its prevention by antioxidant treatment. Neurosci Lett 396:167–171PubMedCrossRef Hazell AS, Normandin L, Norenberg MD, Kennedy G, Jae-Hyuk Y (2006) Alzheimer type II astrocytic changes following sub-acute exposure to manganese and its prevention by antioxidant treatment. Neurosci Lett 396:167–171PubMedCrossRef
Zurück zum Zitat Hernández-Muñoz R, Díaz-Muñoz M, Suárez-Cuenca J, Trejo-Solís C, López V, Sánchez-Sevilla L, Yáñez L, Chagoya V (2001) Adenosine reverses a preestablished CCl4-induced micronodular cirrhosis through enhancing collagenolytic activity and stimulating hepatocyte cell proliferation in rats. Hepatology 34:677–687PubMedCrossRef Hernández-Muñoz R, Díaz-Muñoz M, Suárez-Cuenca J, Trejo-Solís C, López V, Sánchez-Sevilla L, Yáñez L, Chagoya V (2001) Adenosine reverses a preestablished CCl4-induced micronodular cirrhosis through enhancing collagenolytic activity and stimulating hepatocyte cell proliferation in rats. Hepatology 34:677–687PubMedCrossRef
Zurück zum Zitat Jover R, Rodrigo R, Felipo V, Insausti R, Sáez-Valero J, García-Ayllón MS, Suárez I, Candela A, Compañ A, Esteban A, Cauli O, Ausó E, Rodríguez E, Gutiérrez A, Girona E, Erceg S, Berbel P, Pérez-Mateo M (2006) Brain edema and inflamatory activation in bile duct ligated rats with diet-induced hyperammonemia: a model of hepatic encephalopathy. Hepatology 43:1257–1266PubMedCrossRef Jover R, Rodrigo R, Felipo V, Insausti R, Sáez-Valero J, García-Ayllón MS, Suárez I, Candela A, Compañ A, Esteban A, Cauli O, Ausó E, Rodríguez E, Gutiérrez A, Girona E, Erceg S, Berbel P, Pérez-Mateo M (2006) Brain edema and inflamatory activation in bile duct ligated rats with diet-induced hyperammonemia: a model of hepatic encephalopathy. Hepatology 43:1257–1266PubMedCrossRef
Zurück zum Zitat Kountouras J, Billing BH, Scheuer PJ (1984) Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol 65:305–311PubMed Kountouras J, Billing BH, Scheuer PJ (1984) Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol 65:305–311PubMed
Zurück zum Zitat Kulisevsky J, Pujol J, Junque C, Deus J, Balanzo J, Capdevila A (1993) MRI pallidal hyperintensity and brain atrophy in cirrhotic patients: two different MRI patterns of clinical deterioration? Neurology 43:2570–2573PubMed Kulisevsky J, Pujol J, Junque C, Deus J, Balanzo J, Capdevila A (1993) MRI pallidal hyperintensity and brain atrophy in cirrhotic patients: two different MRI patterns of clinical deterioration? Neurology 43:2570–2573PubMed
Zurück zum Zitat Ledig M, Tholey G, Megias-Megias L, Kopp P, Wedler F (1991) Combined effects of ethanol and manganese on cultured neurons and glia. Neurochem Res 16:591–596PubMedCrossRef Ledig M, Tholey G, Megias-Megias L, Kopp P, Wedler F (1991) Combined effects of ethanol and manganese on cultured neurons and glia. Neurochem Res 16:591–596PubMedCrossRef
Zurück zum Zitat Levy BS, Nassetta WJ (2003) Neurologic effects of manganese in humans. Int J Occup Environ Health 9:153–163PubMed Levy BS, Nassetta WJ (2003) Neurologic effects of manganese in humans. Int J Occup Environ Health 9:153–163PubMed
Zurück zum Zitat Montes S, Alcaraz-Zubeldia M, Muriel P, Ríos C (2001) Striatal manganese accumulation induces changes in dopamine metabolism in the cirrhotic rat. Brain Res 891:123–129PubMedCrossRef Montes S, Alcaraz-Zubeldia M, Muriel P, Ríos C (2001) Striatal manganese accumulation induces changes in dopamine metabolism in the cirrhotic rat. Brain Res 891:123–129PubMedCrossRef
Zurück zum Zitat Montes S, Alcaraz-Zubeldia M, Ríos C, Muriel P (2002) A method to induce manganese accumulation in the brain of the cirrhotic rat and its evaluation. Brain Res Brain Res Protoc 9:9–15PubMedCrossRef Montes S, Alcaraz-Zubeldia M, Ríos C, Muriel P (2002) A method to induce manganese accumulation in the brain of the cirrhotic rat and its evaluation. Brain Res Brain Res Protoc 9:9–15PubMedCrossRef
Zurück zum Zitat Montes S, Alcaraz-Zubeldia M, Muriel P, Ríos C (2003) Role of Manganese accumulation in increased brain glutamine of the cirrhotic rat. Neurochem Res 28:911–917PubMedCrossRef Montes S, Alcaraz-Zubeldia M, Muriel P, Ríos C (2003) Role of Manganese accumulation in increased brain glutamine of the cirrhotic rat. Neurochem Res 28:911–917PubMedCrossRef
Zurück zum Zitat Muriel P (1998) Nitric oxide protection of rat liver from lipid peroxidation, collagen accumulation, and liver damage induced by carbon tetrachloride. Biochem Pharmacol 56:773–779PubMedCrossRef Muriel P (1998) Nitric oxide protection of rat liver from lipid peroxidation, collagen accumulation, and liver damage induced by carbon tetrachloride. Biochem Pharmacol 56:773–779PubMedCrossRef
Zurück zum Zitat Norenberg MD (1981) The astrocyte in liver disease. Adv Cell Neurobiol 2:303–352 Norenberg MD (1981) The astrocyte in liver disease. Adv Cell Neurobiol 2:303–352
Zurück zum Zitat Norenberg MD, Lapham LW, Nichols FA, May AG (1974) An experimental model for the study of hepatic encephalopathy. Arch Neurol 31:106–109PubMed Norenberg MD, Lapham LW, Nichols FA, May AG (1974) An experimental model for the study of hepatic encephalopathy. Arch Neurol 31:106–109PubMed
Zurück zum Zitat Normandin L, Hazell A (2002) Manganese neurotoxicity: an update of pathophysiologic mechanisms. Metab Brain Dis 17:375–387PubMedCrossRef Normandin L, Hazell A (2002) Manganese neurotoxicity: an update of pathophysiologic mechanisms. Metab Brain Dis 17:375–387PubMedCrossRef
Zurück zum Zitat Papavasiliou PS, Miller ST, Cotzias GC (1966) Role of liver in regulating distribution and excretion of manganese. Am J Physiol 211:211–216PubMed Papavasiliou PS, Miller ST, Cotzias GC (1966) Role of liver in regulating distribution and excretion of manganese. Am J Physiol 211:211–216PubMed
Zurück zum Zitat Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, 4th edn. Academic, San Diego Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, 4th edn. Academic, San Diego
Zurück zum Zitat Pentschew A, Ebner F, Kovatch R (1963) Experimental manganese encephalopathy in monkeys. A preliminary report. J Neuropathol Exp Neurol 22:488–489PubMedCrossRef Pentschew A, Ebner F, Kovatch R (1963) Experimental manganese encephalopathy in monkeys. A preliminary report. J Neuropathol Exp Neurol 22:488–489PubMedCrossRef
Zurück zum Zitat Pomier-Layrargues G, Spahr L, Butterworth RF (1995) Increased manganese concentrations in pallidum of cirrhotic patients. Lancet 345:735PubMedCrossRef Pomier-Layrargues G, Spahr L, Butterworth RF (1995) Increased manganese concentrations in pallidum of cirrhotic patients. Lancet 345:735PubMedCrossRef
Zurück zum Zitat Reitman S, Frankel S (1957) A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol 28:56–63PubMed Reitman S, Frankel S (1957) A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol 28:56–63PubMed
Zurück zum Zitat Rodrigo R, Montoliu C, Chatauret N, Butterworth RF, Behrends S, del Olmo JA, Serra MA, Rodrigo JM, Erceg S, Felipo V (2004) Alterations in soluble guanylate cyclase content and modulation by nitric oxide in liver disease. Neurochem Int 45:947–953PubMedCrossRef Rodrigo R, Montoliu C, Chatauret N, Butterworth RF, Behrends S, del Olmo JA, Serra MA, Rodrigo JM, Erceg S, Felipo V (2004) Alterations in soluble guanylate cyclase content and modulation by nitric oxide in liver disease. Neurochem Int 45:947–953PubMedCrossRef
Zurück zum Zitat Sistrunk SC, Ross MK, Filipov NM (2007) Direct effects of manganese compounds on dopamine and its metabolite Dopac: An in vitro study. Environ Toxicol Pharmacol 23:286–296PubMedCrossRef Sistrunk SC, Ross MK, Filipov NM (2007) Direct effects of manganese compounds on dopamine and its metabolite Dopac: An in vitro study. Environ Toxicol Pharmacol 23:286–296PubMedCrossRef
Zurück zum Zitat Sloot WN, Gramsbergen JB (1994) Axonal transport of manganese and its relevance to selective neurotoxicity in the rat basal ganglia. Brain Res 657:124–132PubMedCrossRef Sloot WN, Gramsbergen JB (1994) Axonal transport of manganese and its relevance to selective neurotoxicity in the rat basal ganglia. Brain Res 657:124–132PubMedCrossRef
Zurück zum Zitat vom Dahl S, Kircheis G, Häussinger D (2001) Hepatic encephalopathy as a complication of liver disease. World J Gastroenterol 7:152–156 vom Dahl S, Kircheis G, Häussinger D (2001) Hepatic encephalopathy as a complication of liver disease. World J Gastroenterol 7:152–156
Zurück zum Zitat Weissenborn K, Ehrenheim CH, Hori A, Kubicka S, Manns MP (1995) Pallidal lesions in patients with liver cirrhosis: clinical and MRI evaluation. Metab Brain Dis 10:219–231PubMedCrossRef Weissenborn K, Ehrenheim CH, Hori A, Kubicka S, Manns MP (1995) Pallidal lesions in patients with liver cirrhosis: clinical and MRI evaluation. Metab Brain Dis 10:219–231PubMedCrossRef
Zurück zum Zitat Yamada M, Ohno S, Okayasu I, Okeda R, Hatakeyama S, Watanabe H, Ushio K, Tsukagoshi H (1986) Chronic manganese poisoning: a neuropathological study with determination of manganese distribution in the brain. Acta Neuropathol 70:273–278PubMedCrossRef Yamada M, Ohno S, Okayasu I, Okeda R, Hatakeyama S, Watanabe H, Ushio K, Tsukagoshi H (1986) Chronic manganese poisoning: a neuropathological study with determination of manganese distribution in the brain. Acta Neuropathol 70:273–278PubMedCrossRef
Metadaten
Titel
Morphological changes of rat astrocytes induced by liver damage but not by manganese chloride exposure
verfasst von
Susana Rivera-Mancía
Sergio Montes
Maricela Méndez-Armenta
Pablo Muriel
Camilo Ríos
Publikationsdatum
01.06.2009
Verlag
Springer US
Erschienen in
Metabolic Brain Disease / Ausgabe 2/2009
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-009-9138-5

Weitere Artikel der Ausgabe 2/2009

Metabolic Brain Disease 2/2009 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.